lOMoAR cPSD| 32744169
Test nQBank nQfor nQIntroductory nQClinical nQPharmacology nQ12th
nQEdition nQFord
Introductory Clinical nQ
nQ Pharmacology 12th Edition nQ nQ
FordTest Bank
nQ Q
n nQ
, lOMoAR cPSD| 32744169
Test nQBank nQfor nQIntroductory nQClinical nQPharmacology nQ12th
nQEdition nQFord
1. A nQnursing nQinstructor nQis nQpreparing nQa nQteaching nQplan nQfor nQa nQgroup nQof nQnursing
nQstudents nQabout nQpharmacology. nQWhen nQdescribing nQthis nQtopic, nQthe nQinstructor
nQwould nQfocus nQthe nQdiscussion nQonnQ which nQof nQthe nQfollowing nQas nQan nQessential nQaspect?
A) Drug nQname
B) Drug nQclass
C) Drug nQaction
D) Drug
nQsourcen QAns: n Q C
nQFeedback:
Pharmacology nQis nQthe nQstudy nQof nQdrugs nQand nQtheir nQaction nQon nQliving nQorganisms.
nQThus, nQan nQessential nQaspect nQof nQpharmacology nQis nQdrug nQaction. nQAn
nQunderstanding nQof nQthe nQdrug nQname,nQ drug nQclass, nQand nQdrug nQsource nQis nQimportant,
nQbut nQthe nQmost nQcritical nQaspect nQrelated nQto nQpharmacology nQis nQhow nQthe nQdrug nQacts
nQin nQthe nQbody.
2. A nQnursing nQstudent nQis nQpreparing nQto nQadminister nQa nQprescribed nQdrug nQto nQa nQpatient.
nQThe nQstudent nQreviews nQinformation nQabout nQthe nQdrug nQand nQits nQactions. nQWhich nQof
nQthe nQfollowing nQwould nQbe nQthenQbest nQchoice nQfor nQobtaining nQthis nQinformation? nQSelect
nQall nQthat nQapply.
A) Nursing nQinstructor
B) Nurse nQassigned nQto nQthe nQpatient
C) Clinical nQdrug nQreference
D) Prescribing nQhealth nQcare nQprovider
E) Clinical
nQpharmacistn QAns: n Q C, nQE
Feedback:
Although nQthe nQnursing nQstudent nQcan nQask nQthe nQnursing nQinstructor, nQthe nQnurse
nQassigned nQto nQthe nQpatient, nQand nQthe nQprescribing nQhealth nQcare nQprovider nQfor
nQinformation nQabout nQthe nQdrug, nQthe nQbestnQchoices nQfor nQdrug nQinformation nQwould
nQinclude nQan nQappropriate nQdrug nQreference nQand nQthe nQclinical nQpharmacist.
3. When nQdescribing nQthe nQvarious nQtypes nQof nQmedications nQto nQa nQgroup nQof nQnursing
nQstudents, nQan
Qnursing nQinstructor nQwould nQidentify nQwhich nQof nQthe nQfollowing nQas nQa
nQsource nQfor nQderiving nQmedications? nQSelect nQall nQthat nQapply.
A) Plants
B) Synthetic nQsources
C) Mold
D) Minerals
E) Animals
nQAns: nQA, nQB, nQC,
nQD, nQEn
Feedback:
Q
Medications nQare nQderived nQfrom nQnatural nQsources, nQfor nQexample, nQplants, nQmolds,
nQminerals, nQandn animals, nQas nQwell nQas nQcreated nQsynthetically nQin nQa nQlaboratory.
Q
Page n Q 1
, lOMoAR cPSD| 32744169
Test nQBank nQfor nQIntroductory nQClinical nQPharmacology nQ12th
nQEdition nQFord
4. Which nQof nQthe nQfollowing nQnames nQmay nQbe nQassigned nQto nQa nQdrug nQduring
nQthe nQprocess nQofn
development? nQSelect nQall nQthat nQapply.
Q
A) Chemical nQname
B) Official nQname
C) Pharmacologic nQname
D) Trade nQname
E) Nonproprietary
nQnamen Ans: n Q A, nQB, nQD,
Q
nQE nQFeedback:
Throughout nQthe nQprocess nQof nQdevelopment, nQdrugs nQmay nQhave nQseveral nQnames
nQassigned nQto nQthem nQincluding nQa nQchemical nQname, nQa nQgeneric nQ(nonproprietary)
nQname, nQan nQofficial nQname, nQandnQ
a nQtrade nQor nQbrand nQname.
5. A nQdrug nQmay nQbe nQclassified nQby nQwhich nQof nQthe nQfollowing? nQSelect nQall nQthat nQapply.
A) The nQchemical nQtype nQof nQthe nQdrug's nQactive nQingredient
B) The nQway nQthe nQdrug nQis nQused nQto nQtreat nQa nQspecific nQcondition
C) The nQgeneric nQname nQof nQthe nQdrug
D) The nQtrade nQname nQof nQthe nQdrug
E) The nQnonproprietary nQname nQof nQthe
nQdrugn Ans: n Q A, nQB
Q
Feedback:
A nQdrug nQmay nQbe nQclassified nQby nQthe nQchemical nQtype nQof nQthe nQactive nQingredient nQor nQby
nQthe nQway nQit nQisn
Qused nQto nQtreat nQa nQparticular nQcondition. nQGeneric, nQtrade, nQand
nQnonproprietary nQrefer nQto nQhow nQa nQdrug nQis nQnamed.
6. A nQgroup nQof nQnursing nQstudents nQare nQreviewing nQinformation nQabout nQthe nQprocess
nQof nQdrug nQdevelopment nQin nQthe nQUnited nQStates. nQThe nQstudents nQdemonstrate
nQunderstanding nQof nQthis nQprocess nQwhen nQthey nQidentify nQthat nQwhich nQof nQthe
nQfollowing nQcategories nQare nQassigned nQby nQthenQ Food nQand nQDrug nQAdministration nQto
nQnewly nQapproved nQdrugs? nQSelect nQall nQthat nQapply.
A) Metabolite
B) Noncontrolled nQsubstance
C) Prescription
D) Nonprescription
E) Controlled
nQsubstancen Ans: n Q C, nQD, nQE
Q
Feedback:
Once nQdrugs nQare nQapproved nQfor nQuse, nQthe nQFDA nQassigns nQthe nQdrug nQto nQone nQof nQthe
nQfollowing nQcategories: nQprescription, nQnonprescription, nQor nQcontrolled nQsubstance.
nQMetabolite nQrefers nQton the nQinactive nQform nQof nQthe nQdrug. nQNoncontrolled nQsubstance
Q
nQis nQa nQterm nQthat nQis nQnot nQused.
Page n Q 2
, lOMoAR cPSD| 32744169
Test nQBank nQfor nQIntroductory nQClinical nQPharmacology nQ12th
nQEdition nQFord
7. Which nQof nQthe nQfollowing nQwould nQbe nQmost nQimportant nQfor nQthe nQnurse nQto nQdo nQto
nQensure nQthe nQsafen use nQof nQprescription nQdrugs nQin nQthe nQinstitutional nQsetting? nQSelect
Q
nQall nQthat nQapply.
A) Administering nQdrugs
B) Monitoring nQclients nQfor nQdrug nQeffects
C) Prescribing nQdrugs
D) Evaluating nQclients nQfor nQtoxic nQeffects
E) Educating nQclients/caregivers nQabout
nQdrugsn Ans: n Q A, nQB, nQD, nQE
Q
Feedback:
In nQthe nQinstitutional nQsetting, nQthe nQnurse's nQrole nQto nQensure nQsafe nQuse nQof nQprescription
nQdrugs nQincludes nQadministering nQdrugs, nQmonitoring nQdrug nQeffects, nQevaluating nQfor
nQtoxic nQeffects, nQandn educating nQclients nQand nQcaregivers nQabout nQdrugs.
Q
8. The nQnurse nQis nQhelping nQa nQclient nQreview nQa nQprescription nQfrom nQthe nQhealth nQcare
nQprovider. nQWhenn examining nQthe nQprescription, nQwhich nQof nQthe nQfollowing nQwould nQthe
Q
nQnurse nQexpect nQto nQfind nQdocumented? nQSelect nQall nQthat nQapply.
A) Name nQof nQthe nQdrug
B) Dosage nQof nQthe nQdrug
C) Route nQof nQdrug nQadministration
D) Times nQof nQdrug nQadministration
E) Licensed nQprescriber's
nQsignaturenAns: n Q A, nQB, nQC, nQD, nQE
Q
Feedback:
The nQprescription nQmust nQcontain nQthe nQclient's nQname, nQthe nQname nQof nQthe nQdrug, nQthe
nQdosage, nQthen
Qmethod nQand nQtimes nQof nQadministration, nQand nQthe nQsignature nQof nQthe
nQlicensed nQhealth nQcare nQprovider nQprescribing nQthe nQdrug.
9. After nQteaching nQa nQgroup nQof nQnursing nQstudents nQabout nQnonprescription nQdrugs, nQthe
nQnursing nQinstructor nQdetermines nQthat nQthe nQteaching nQwas nQsuccessful nQwhen nQthe
nQstudents nQidentify nQwhichn of nQthe nQfollowing? nQSelect nQall nQthat nQapply.
Q
A) They nQrequire nQa nQlicensed nQhealth nQcare nQprovider's nQsignature.
B) They nQare nQreferred nQto nQas nQover-the-counter nQdrugs.
C) They nQcan nQbe nQtaken nQwithout nQrisk nQto nQthe nQclient.
D) They nQhave nQcertain nQlabeling nQrequirements.
E) They nQshould nQbe nQtaken nQonly nQas nQdirected nQon
nQthe nQlabel.n
Ans: n Q B, nQD, nQE
Q
Feedback:
Nonprescription nQdrugs nQare nQoften nQreferred nQto nQas nQover-the-counter nQ(OTC) nQdrugs.
nQThey nQdo nQnot nQrequire nQa nQprescription nQ(a nQlicensed nQhealth nQcare nQprovider's
nQsignature) nQbut nQdo nQnot nQcome nQwithout nQrisk nQto nQthe nQclient. nQThe nQfederal
nQgovernment nQhas nQimposed nQlabeling nQrequirements nQofnQ OTC nQdrugs nQand nQthey nQshould
nQonly nQbe nQtaken nQas nQdirected nQon nQthe nQlabel nQunless nQunder nQthe nQsupervision nQof nQa
nQhealth nQcare nQprovider.
Page n Q 3
Test nQBank nQfor nQIntroductory nQClinical nQPharmacology nQ12th
nQEdition nQFord
Introductory Clinical nQ
nQ Pharmacology 12th Edition nQ nQ
FordTest Bank
nQ Q
n nQ
, lOMoAR cPSD| 32744169
Test nQBank nQfor nQIntroductory nQClinical nQPharmacology nQ12th
nQEdition nQFord
1. A nQnursing nQinstructor nQis nQpreparing nQa nQteaching nQplan nQfor nQa nQgroup nQof nQnursing
nQstudents nQabout nQpharmacology. nQWhen nQdescribing nQthis nQtopic, nQthe nQinstructor
nQwould nQfocus nQthe nQdiscussion nQonnQ which nQof nQthe nQfollowing nQas nQan nQessential nQaspect?
A) Drug nQname
B) Drug nQclass
C) Drug nQaction
D) Drug
nQsourcen QAns: n Q C
nQFeedback:
Pharmacology nQis nQthe nQstudy nQof nQdrugs nQand nQtheir nQaction nQon nQliving nQorganisms.
nQThus, nQan nQessential nQaspect nQof nQpharmacology nQis nQdrug nQaction. nQAn
nQunderstanding nQof nQthe nQdrug nQname,nQ drug nQclass, nQand nQdrug nQsource nQis nQimportant,
nQbut nQthe nQmost nQcritical nQaspect nQrelated nQto nQpharmacology nQis nQhow nQthe nQdrug nQacts
nQin nQthe nQbody.
2. A nQnursing nQstudent nQis nQpreparing nQto nQadminister nQa nQprescribed nQdrug nQto nQa nQpatient.
nQThe nQstudent nQreviews nQinformation nQabout nQthe nQdrug nQand nQits nQactions. nQWhich nQof
nQthe nQfollowing nQwould nQbe nQthenQbest nQchoice nQfor nQobtaining nQthis nQinformation? nQSelect
nQall nQthat nQapply.
A) Nursing nQinstructor
B) Nurse nQassigned nQto nQthe nQpatient
C) Clinical nQdrug nQreference
D) Prescribing nQhealth nQcare nQprovider
E) Clinical
nQpharmacistn QAns: n Q C, nQE
Feedback:
Although nQthe nQnursing nQstudent nQcan nQask nQthe nQnursing nQinstructor, nQthe nQnurse
nQassigned nQto nQthe nQpatient, nQand nQthe nQprescribing nQhealth nQcare nQprovider nQfor
nQinformation nQabout nQthe nQdrug, nQthe nQbestnQchoices nQfor nQdrug nQinformation nQwould
nQinclude nQan nQappropriate nQdrug nQreference nQand nQthe nQclinical nQpharmacist.
3. When nQdescribing nQthe nQvarious nQtypes nQof nQmedications nQto nQa nQgroup nQof nQnursing
nQstudents, nQan
Qnursing nQinstructor nQwould nQidentify nQwhich nQof nQthe nQfollowing nQas nQa
nQsource nQfor nQderiving nQmedications? nQSelect nQall nQthat nQapply.
A) Plants
B) Synthetic nQsources
C) Mold
D) Minerals
E) Animals
nQAns: nQA, nQB, nQC,
nQD, nQEn
Feedback:
Q
Medications nQare nQderived nQfrom nQnatural nQsources, nQfor nQexample, nQplants, nQmolds,
nQminerals, nQandn animals, nQas nQwell nQas nQcreated nQsynthetically nQin nQa nQlaboratory.
Q
Page n Q 1
, lOMoAR cPSD| 32744169
Test nQBank nQfor nQIntroductory nQClinical nQPharmacology nQ12th
nQEdition nQFord
4. Which nQof nQthe nQfollowing nQnames nQmay nQbe nQassigned nQto nQa nQdrug nQduring
nQthe nQprocess nQofn
development? nQSelect nQall nQthat nQapply.
Q
A) Chemical nQname
B) Official nQname
C) Pharmacologic nQname
D) Trade nQname
E) Nonproprietary
nQnamen Ans: n Q A, nQB, nQD,
Q
nQE nQFeedback:
Throughout nQthe nQprocess nQof nQdevelopment, nQdrugs nQmay nQhave nQseveral nQnames
nQassigned nQto nQthem nQincluding nQa nQchemical nQname, nQa nQgeneric nQ(nonproprietary)
nQname, nQan nQofficial nQname, nQandnQ
a nQtrade nQor nQbrand nQname.
5. A nQdrug nQmay nQbe nQclassified nQby nQwhich nQof nQthe nQfollowing? nQSelect nQall nQthat nQapply.
A) The nQchemical nQtype nQof nQthe nQdrug's nQactive nQingredient
B) The nQway nQthe nQdrug nQis nQused nQto nQtreat nQa nQspecific nQcondition
C) The nQgeneric nQname nQof nQthe nQdrug
D) The nQtrade nQname nQof nQthe nQdrug
E) The nQnonproprietary nQname nQof nQthe
nQdrugn Ans: n Q A, nQB
Q
Feedback:
A nQdrug nQmay nQbe nQclassified nQby nQthe nQchemical nQtype nQof nQthe nQactive nQingredient nQor nQby
nQthe nQway nQit nQisn
Qused nQto nQtreat nQa nQparticular nQcondition. nQGeneric, nQtrade, nQand
nQnonproprietary nQrefer nQto nQhow nQa nQdrug nQis nQnamed.
6. A nQgroup nQof nQnursing nQstudents nQare nQreviewing nQinformation nQabout nQthe nQprocess
nQof nQdrug nQdevelopment nQin nQthe nQUnited nQStates. nQThe nQstudents nQdemonstrate
nQunderstanding nQof nQthis nQprocess nQwhen nQthey nQidentify nQthat nQwhich nQof nQthe
nQfollowing nQcategories nQare nQassigned nQby nQthenQ Food nQand nQDrug nQAdministration nQto
nQnewly nQapproved nQdrugs? nQSelect nQall nQthat nQapply.
A) Metabolite
B) Noncontrolled nQsubstance
C) Prescription
D) Nonprescription
E) Controlled
nQsubstancen Ans: n Q C, nQD, nQE
Q
Feedback:
Once nQdrugs nQare nQapproved nQfor nQuse, nQthe nQFDA nQassigns nQthe nQdrug nQto nQone nQof nQthe
nQfollowing nQcategories: nQprescription, nQnonprescription, nQor nQcontrolled nQsubstance.
nQMetabolite nQrefers nQton the nQinactive nQform nQof nQthe nQdrug. nQNoncontrolled nQsubstance
Q
nQis nQa nQterm nQthat nQis nQnot nQused.
Page n Q 2
, lOMoAR cPSD| 32744169
Test nQBank nQfor nQIntroductory nQClinical nQPharmacology nQ12th
nQEdition nQFord
7. Which nQof nQthe nQfollowing nQwould nQbe nQmost nQimportant nQfor nQthe nQnurse nQto nQdo nQto
nQensure nQthe nQsafen use nQof nQprescription nQdrugs nQin nQthe nQinstitutional nQsetting? nQSelect
Q
nQall nQthat nQapply.
A) Administering nQdrugs
B) Monitoring nQclients nQfor nQdrug nQeffects
C) Prescribing nQdrugs
D) Evaluating nQclients nQfor nQtoxic nQeffects
E) Educating nQclients/caregivers nQabout
nQdrugsn Ans: n Q A, nQB, nQD, nQE
Q
Feedback:
In nQthe nQinstitutional nQsetting, nQthe nQnurse's nQrole nQto nQensure nQsafe nQuse nQof nQprescription
nQdrugs nQincludes nQadministering nQdrugs, nQmonitoring nQdrug nQeffects, nQevaluating nQfor
nQtoxic nQeffects, nQandn educating nQclients nQand nQcaregivers nQabout nQdrugs.
Q
8. The nQnurse nQis nQhelping nQa nQclient nQreview nQa nQprescription nQfrom nQthe nQhealth nQcare
nQprovider. nQWhenn examining nQthe nQprescription, nQwhich nQof nQthe nQfollowing nQwould nQthe
Q
nQnurse nQexpect nQto nQfind nQdocumented? nQSelect nQall nQthat nQapply.
A) Name nQof nQthe nQdrug
B) Dosage nQof nQthe nQdrug
C) Route nQof nQdrug nQadministration
D) Times nQof nQdrug nQadministration
E) Licensed nQprescriber's
nQsignaturenAns: n Q A, nQB, nQC, nQD, nQE
Q
Feedback:
The nQprescription nQmust nQcontain nQthe nQclient's nQname, nQthe nQname nQof nQthe nQdrug, nQthe
nQdosage, nQthen
Qmethod nQand nQtimes nQof nQadministration, nQand nQthe nQsignature nQof nQthe
nQlicensed nQhealth nQcare nQprovider nQprescribing nQthe nQdrug.
9. After nQteaching nQa nQgroup nQof nQnursing nQstudents nQabout nQnonprescription nQdrugs, nQthe
nQnursing nQinstructor nQdetermines nQthat nQthe nQteaching nQwas nQsuccessful nQwhen nQthe
nQstudents nQidentify nQwhichn of nQthe nQfollowing? nQSelect nQall nQthat nQapply.
Q
A) They nQrequire nQa nQlicensed nQhealth nQcare nQprovider's nQsignature.
B) They nQare nQreferred nQto nQas nQover-the-counter nQdrugs.
C) They nQcan nQbe nQtaken nQwithout nQrisk nQto nQthe nQclient.
D) They nQhave nQcertain nQlabeling nQrequirements.
E) They nQshould nQbe nQtaken nQonly nQas nQdirected nQon
nQthe nQlabel.n
Ans: n Q B, nQD, nQE
Q
Feedback:
Nonprescription nQdrugs nQare nQoften nQreferred nQto nQas nQover-the-counter nQ(OTC) nQdrugs.
nQThey nQdo nQnot nQrequire nQa nQprescription nQ(a nQlicensed nQhealth nQcare nQprovider's
nQsignature) nQbut nQdo nQnot nQcome nQwithout nQrisk nQto nQthe nQclient. nQThe nQfederal
nQgovernment nQhas nQimposed nQlabeling nQrequirements nQofnQ OTC nQdrugs nQand nQthey nQshould
nQonly nQbe nQtaken nQas nQdirected nQon nQthe nQlabel nQunless nQunder nQthe nQsupervision nQof nQa
nQhealth nQcare nQprovider.
Page n Q 3
